Literature DB >> 3093540

New marker for mesothelioma: an immunoperoxidase study.

A Donna, P G Betta, D Bellingeri, A Marchesini.   

Abstract

An antibody was raised against a protein isolated from the cytoplasm of mesothelioma cells. It was subsequently used in an immunoperoxidase procedure on formalin fixed, paraffin embedded tissue sections. A representative sample of benign and malignant tumours from all the systems of the human body was examined. All the tumours derived from coelomic surfaces (mesotheliomas of pleura, peritoneum, and ovary, and adenomatoid tumour of epididymis) reacted with the antibody. No other tumour tested in this study expressed the protein. These findings indicate that the antibody may be useful in the identification of mesothelioma cells in both histological and cytological diagnostic routine practice when morphological interpretation is in doubt.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093540      PMCID: PMC500194          DOI: 10.1136/jcp.39.9.961

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.

Authors:  H Battifora; M I Kopinski
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

2.  The ovarian mesothelioma.

Authors:  T H Parmley; J D Woodruff
Journal:  Am J Obstet Gynecol       Date:  1974-09-15       Impact factor: 8.661

3.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructure comparison.

Authors:  A Blaustein; H Lee
Journal:  Gynecol Oncol       Date:  1979-08       Impact factor: 5.482

6.  Isolation and characterization of a possible new protein marker for differential diagnosis between metastatic carcinoma and mesothelioma cells in serous effusions: preliminary findings.

Authors:  A Donna; P G Betta; A Marchesini
Journal:  Cancer Detect Prev       Date:  1985

Review 7.  Diagnosis of pleural malignant mesothelioma in life--a practical approach.

Authors:  D Whitaker; K B Shilkin
Journal:  J Pathol       Date:  1984-07       Impact factor: 7.996

8.  Immunodiagnosis of mesothelioma: use of antimesothelial cell serum in an indirect immunofluorescence assay.

Authors:  G Singh; T L Whiteside; A Dekker
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

9.  Immunohistological study of malignant diffuse mesotheliomas of the pleura.

Authors:  H Loosli; J Hurlimann
Journal:  Histopathology       Date:  1984-09       Impact factor: 5.087

10.  Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.

Authors:  R J Marshall; A Herbert; S G Braye; D B Jones
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

View more
  4 in total

1.  Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.

Authors:  A Donna; P G Betta; F Robutti
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

Review 2.  Mesotheliomas of the tunica vaginalis testis and hernial sacs.

Authors:  A Grove; M L Jensen; A Donna
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  [Pleural mesothelioma--problems in diagnosis and clinical course in 25 patients].

Authors:  F Liewald; L Sunder-Plassmann; H Dienemann; J Mezger
Journal:  Langenbecks Arch Chir       Date:  1989

4.  ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.

Authors:  C J O'Hara; J M Corson; G S Pinkus; R A Stahel
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.